intramuscular injection of naltrexone prior to discharge.51 The likelihood of no binge drinking increased in both groups, going from 13.6% during pre-treatment to 75.0% at 45 days post-treatment in the oral naltrexone group and from 13.6% to 77.8% in the long-acting naltrexone group. The study’s short duration and small sample size did not allow for an adequate test of the difference between the two formulations.
